Related Experiment Video
Updated: Nov 22, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
The sequence of structural, functional and cognitive changes in multiple sclerosis
Iris Dekker1, Menno M Schoonheim2, Vikram Venkatraghavan3
1Amsterdam UMC, Location VUmc, Departments of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam Neuroscience, De Boelelaan 1117, Amsterdam, The Netherlands; Neurology, MS Center Amsterdam, Amsterdam Neuroscience, De Boelelaan 1117, Amsterdam, The Netherlands.
Background:
As disease progression remains poorly understood in multiple sclerosis (MS), we aim to investigate the sequence in which different disease milestones occur using a novel data-driven approach.
Methods:
We analysed a cohort of 295 relapse-onset MS patients and 96 healthy controls, and considered 28 features, capturing information on T2-lesion load, regional brain and spinal cord volumes, resting-state functional centrality ("hubness"), microstructural tissue integrity of major white matter (WM) tracts and performance on multiple cognitive tests. We used a discriminative event-based model to estimate the sequence of biomarker abnormality in MS progression in general, as well as specific models for worsening physical disability and cognitive impairment.
Results:
We demonstrated that grey matter (GM) atrophy of the cerebellum, thalamus, and changes in corticospinal tracts are early events in MS pathology, whereas other WM tracts as well as the cognitive domains of working memory, attention, and executive function are consistently late events. The models for disability and cognition show early functional changes of the default-mode network and earlier changes in spinal cord volume compared to the general MS population. Overall, GM atrophy seems crucial due to its early involvement in the disease course, whereas WM tract integrity appears to be affected relatively late despite the early onset of WM lesions.
Conclusion:
Data-driven modelling revealed the relative occurrence of both imaging and non-imaging events as MS progresses, providing insights into disease propagation mechanisms, and allowing fine-grained staging of patients for monitoring purposes.
Insights
Grey matter atrophy in multiple sclerosis (MS) occurs early, while white matter changes and cognitive decline manifest later. This study maps the sequence of MS disease events for better patient monitoring.
Area of Science:
- Neuroscience
- Medical Imaging
- Biostatistics
Background:
- Multiple sclerosis (MS) disease progression and its underlying mechanisms remain incompletely understood.
- Identifying the sequence of clinical and imaging events is crucial for effective patient management.
Purpose of the Study:
- To investigate the temporal sequence of biomarker abnormalities in multiple sclerosis (MS) progression.
- To understand the order of physical disability and cognitive impairment milestones in MS.
- To apply a novel data-driven approach to model MS disease trajectory.
Main Methods:
- Analysis of a cohort comprising 295 relapse-onset MS patients and 96 healthy controls.
- Utilized 28 features including T2-lesion load, regional brain/spinal cord volumes, functional centrality, white matter integrity, and cognitive test performance.
- Employed a discriminative event-based model to determine the sequence of biomarker abnormalities.
Main Results:
- Grey matter (GM) atrophy in the cerebellum and thalamus, and corticospinal tract changes are early MS events.
- White matter tract integrity and cognitive functions (working memory, attention, executive function) are affected later in the disease course.
- Early functional changes in the default-mode network and spinal cord volume were observed compared to the general MS population.
Conclusions:
- Data-driven modeling elucidated the sequence of imaging and non-imaging events in MS progression.
- Findings provide insights into MS disease propagation mechanisms.
- The study enables fine-grained patient staging for improved monitoring and management of multiple sclerosis.
Related Concept Videos
Cognitive Development During Adulthood
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neuroplasticity
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...

